Consistently, co-culture experiments have shown that anti-FITC CAR-T cells can eliminate ACPA-specific B cells from RA patients via recognition of corresponding FITC-labeled citrullinated peptide epitopes [97]. Here, PRTN3 is linked to rheumatoid arthritis.